# OnCo record nct03936153 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03936153/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03936153", "NCT03936153" ;
  schema:name "Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)"@en ;
  schema:description "A phase 2 trial of Abexinostat in diffuse large b-cell lymphoma, run by Xynomic Pharmaceuticals, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03936153/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03936153> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2020-01-20" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:drugs <https://onco.cc/drugs/abexinostat/> ;
  onco:companies <https://onco.cc/companies/xynomic-pharmaceuticals/> .